Interreg 2 Seas 2014–2020 is a European Territorial Cooperation Program covering England, France, the Netherlands, and Belgium (Flanders). The program is co-financed by the European Regional Development Fund and has a total budget of €241 million from the ERDF to co-finance projects during the period.
The CoBra project is one of the projects funded under this program. It began in January 2018 and has a budget of €3,801,252 for a duration of 57 months.
Its objective is to develop a robot that improves brachytherapy (also known as Curie therapy) by designing a new robot for the diagnosis and treatment of localized cancers such as prostate cancer.
It is led by the CRIStAL laboratory (University of Lille), in partnership with:
- Oscar Lambret Center (FR)
- Delft University of Technology (NL)
- University of Portsmouth (UK)
- Eurasanté (FR)
- Demcon Advanced Mechatronics West B.V. (NL)
- SATT-Nord (FR)
- Oncovet Veterinary Cancer Center (FR)
- Portsmouth Hospital (UK)
- Demcon Advanced Mechatronics B.V. (NL)
SATT Nord is involved in:
- The development of needles
- Intellectual property protection for inventions
- The state of the art in brachytherapy
- Technology transfer
- Communication
More information at:
www.cobra-2seas.eu